NUP188
Basic information
Region (hg38): 9:128947699-129007096
Previous symbols: [ "KIAA0169" ]
Links
Phenotypes
GenCC
Source:
- sandestig-stefanova syndrome (Moderate), mode of inheritance: AR
- sandestig-stefanova syndrome (Strong), mode of inheritance: AR
- sandestig-stefanova syndrome (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Sandestig-Stefanova syndrome | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 32021605; 32275884 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NUP188 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 22 | 27 | ||||
missense | 177 | 16 | 194 | |||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 3 | 3 | 6 | |||
non coding | 10 | |||||
Total | 3 | 6 | 181 | 41 | 12 |
Variants in NUP188
This is a list of pathogenic ClinVar variants found in the NUP188 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-128947707-C-T | DK1-congenital disorder of glycosylation | Benign/Likely benign (Jun 16, 2018) | ||
9-128947714-G-A | DK1-congenital disorder of glycosylation | Uncertain significance (Jan 13, 2018) | ||
9-128947727-C-T | DK1-congenital disorder of glycosylation • Inborn genetic diseases | Uncertain significance (Dec 21, 2023) | ||
9-128947736-G-C | Inborn genetic diseases • NUP188-related disorder | Likely benign (Jan 07, 2022) | ||
9-128947738-G-A | Congenital disorder of glycosylation | Benign/Likely benign (Jun 28, 2018) | ||
9-128947744-T-G | Inborn genetic diseases | Uncertain significance (Nov 17, 2022) | ||
9-128947745-G-A | Inborn genetic diseases | Uncertain significance (Dec 30, 2023) | ||
9-128947846-A-G | Benign (Jun 19, 2018) | |||
9-128947888-G-A | Benign (Jul 09, 2018) | |||
9-128947907-A-G | Likely benign (Jun 16, 2018) | |||
9-128948062-C-T | Benign (Jun 29, 2018) | |||
9-128949197-G-A | Inborn genetic diseases | Uncertain significance (Jul 09, 2024) | ||
9-128949218-T-C | Inborn genetic diseases | Uncertain significance (Nov 08, 2022) | ||
9-128949243-G-A | Inborn genetic diseases | Conflicting classifications of pathogenicity (Jun 04, 2021) | ||
9-128952806-C-T | Inborn genetic diseases | Uncertain significance (Dec 18, 2023) | ||
9-128952809-C-T | Pathogenic (Feb 01, 2023) | |||
9-128956360-G-C | Inborn genetic diseases | Uncertain significance (Jan 10, 2023) | ||
9-128956361-C-G | Inborn genetic diseases | Uncertain significance (Jul 07, 2024) | ||
9-128956378-A-G | Inborn genetic diseases • NUP188-related disorder | Likely benign (Dec 01, 2024) | ||
9-128956978-G-T | Inborn genetic diseases | Uncertain significance (May 02, 2024) | ||
9-128956991-T-TA | Sandestig-stefanova syndrome | Uncertain significance (Oct 01, 2019) | ||
9-128958019-C-T | Sandestig-stefanova syndrome | Likely pathogenic (Dec 01, 2018) | ||
9-128958855-C-T | Likely benign (Dec 31, 2019) | |||
9-128958875-A-G | Inborn genetic diseases | Uncertain significance (Jun 24, 2022) | ||
9-128958885-C-T | NUP188-related disorder | Benign (Nov 11, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NUP188 | protein_coding | protein_coding | ENST00000372577 | 44 | 59398 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.954 | 0.0457 | 125624 | 1 | 123 | 125748 | 0.000493 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.12 | 881 | 980 | 0.899 | 0.0000559 | 11343 |
Missense in Polyphen | 313 | 397.13 | 0.78816 | 4695 | ||
Synonymous | -0.731 | 398 | 380 | 1.05 | 0.0000207 | 3503 |
Loss of Function | 7.29 | 20 | 97.9 | 0.204 | 0.00000483 | 1133 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00145 | 0.00145 |
Ashkenazi Jewish | 0.000397 | 0.000397 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.000141 | 0.000139 |
European (Non-Finnish) | 0.000468 | 0.000466 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000859 | 0.000817 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: May function as a component of the nuclear pore complex (NPC).;
- Disease
- DISEASE: Note=Copy number variations of NUP188 gene may be a cause of heterotaxy, a congenital heart disease resulting from abnormalities in left-right (LR) body patterning. {ECO:0000269|PubMed:21282601}.;
- Pathway
- RNA transport - Homo sapiens (human);tRNA processing;Disease;Gene expression (Transcription);Regulation of HSF1-mediated heat shock response;Metabolism of carbohydrates;Rev-mediated nuclear export of HIV RNA;Late Phase of HIV Life Cycle;HIV Life Cycle;Interactions of Rev with host cellular proteins;Host Interactions of HIV factors;HIV Infection;snRNP Assembly;Vpr-mediated nuclear import of PICs;SUMOylation of DNA damage response and repair proteins;Transport of Ribonucleoproteins into the Host Nucleus;Viral Messenger RNA Synthesis;Export of Viral Ribonucleoproteins from Nucleus;SUMOylation of chromatin organization proteins;Influenza Viral RNA Transcription and Replication;Cellular responses to stress;SUMOylation of RNA binding proteins;Post-translational protein modification;SUMOylation of DNA replication proteins;SUMO E3 ligases SUMOylate target proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Metabolism of proteins;Influenza Life Cycle;Influenza Infection;Metabolism of RNA;Glycolysis and Gluconeogenesis;Infectious disease;Leukotriene metabolism;Squalene and cholesterol biosynthesis;Purine metabolism;Vitamin B3 (nicotinate and nicotinamide) metabolism;Vitamin B5 - CoA biosynthesis from pantothenate;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Pyrimidine metabolism;SUMOylation;Glycosphingolipid metabolism;Cellular responses to external stimuli;Regulation of Glucokinase by Glucokinase Regulatory Protein;Glycolysis;Phosphatidylinositol phosphate metabolism;Lysine metabolism;Methionine and cysteine metabolism;Selenoamino acid metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Aminosugars metabolism;Pentose phosphate pathway;Nuclear Pore Complex (NPC) Disassembly;De novo fatty acid biosynthesis;Glycerophospholipid metabolism;Prostaglandin formation from dihomo gama-linoleic acid;Putative anti-Inflammatory metabolites formation from EPA;Vitamin D3 (cholecalciferol) metabolism;Vitamin E metabolism;tRNA processing in the nucleus;Transport of Mature mRNA derived from an Intron-Containing Transcript;Metabolism of non-coding RNA;Cellular response to heat stress;Nuclear Envelope Breakdown;Mitotic Prophase;M Phase;Nuclear import of Rev protein;Glucose metabolism;Transcriptional regulation by small RNAs;Cell Cycle;Interactions of Vpr with host cellular proteins;Glycine, serine, alanine and threonine metabolism;Cell Cycle, Mitotic;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Arachidonic acid metabolism;Gene Silencing by RNA
(Consensus)
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- loftool
- 0.710
- rvis_EVS
- -1.25
- rvis_percentile_EVS
- 5.37
Haploinsufficiency Scores
- pHI
- 0.663
- hipred
- N
- hipred_score
- 0.250
- ghis
- 0.597
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.842
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nup188
- Phenotype
Gene ontology
- Biological process
- mRNA export from nucleus;protein import into nucleus;viral process;glomerular visceral epithelial cell migration
- Cellular component
- nuclear envelope;membrane;nuclear pore inner ring
- Molecular function
- structural constituent of nuclear pore